Literature DB >> 9152191

Lateral internal sphincterotomy for fissure-in-ano--revisited.

N Hananel1, P H Gordon.   

Abstract

PURPOSE: A disturbing complication rate following lateral internal sphincterotomy (LIS) has recently been reported, and this study assessed our complication rate.
METHODS: Charts of 312 patients who were operated on between January 1975 and December 1993 were reviewed.
RESULTS: There were 148 men (47.5 percent) and 164 women (52.5 percent), ranging in age from 16 to 95 (mean, 40) years. Two hundred sixty-five patients underwent LIS as a primary and sole procedure. Mean follow-up time was 20.4 months (range, 2 weeks-215 months). Healing times were less than one month (11.6 percent), one month (73.2 percent), one to two months (9.6 percent), and more than two months, 5.6 percent. Twenty-three complications (8.7 percent) occurred in 20 (7.5 percent) of the 265 patients: delayed healing (> 60 days) of the sphincterotomy site (13); persistence or recurrence of the fissure (3); wound infection (2); incontinence to flatus (1); soiling (1); temporary incontinence to flatus and stool (1); prolapsed hemorrhoids (1); fecal impaction (1). Most complications were minor and resolved spontaneously. Reoperations included one revision and one hemorrhoidectomy.
CONCLUSIONS: This review supports the belief that LIS is a good operation for patients with chronic anal fissure and can successfully be performed under local anesthetic as an outpatient procedure with an acceptable complication rate.

Entities:  

Mesh:

Year:  1997        PMID: 9152191     DOI: 10.1007/bf02055386

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  9 in total

1.  Usefulness of lateral internal sphincterotomy in reducing postoperative pain after open hemorrhoidectomy.

Authors:  Ioannis Kanellos; Emmanouil Zacharakis; Emmanouil Christoforidis; Stamatis Angelopoulos; Dimitrios Kanellos; Manousos Georgios Pramateftakis; Dimitrios Betsis
Journal:  World J Surg       Date:  2005-04       Impact factor: 3.352

2.  Early results of a rotational flap to treat chronic anal fissures.

Authors:  Meheshinder Singh; Abhiram Sharma; Angela Gardiner; Graeme S Duthie
Journal:  Int J Colorectal Dis       Date:  2004-11-20       Impact factor: 2.571

Review 3.  Botulinum toxin for gastrointestinal disorders: therapy and mechanisms.

Authors:  H Vittal; P F Pasricha
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 4.  What every gastroenterologist needs to know about common anorectal disorders.

Authors:  Moonkyung Cho Schubert; Subbaramiah Sridhar; Robert R Schade; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

5.  Subcutaneous lateral internal sphincterotomy (SLIS)--a safe technique for treatment of chronic anal fissure.

Authors:  Jim S Khan; Neil Tan; Dariush Nikkhah; Andrew J G Miles
Journal:  Int J Colorectal Dis       Date:  2009-07-21       Impact factor: 2.571

6.  Changing patterns of treatment for chronic anal fissure.

Authors:  R Farouk; J Gunn; G S Duthie
Journal:  Ann R Coll Surg Engl       Date:  1998-05       Impact factor: 1.891

7.  Comparative study of conventional lateral internal sphincterotomy, V-Y anoplasty, and tailored lateral internal sphincterotomy with V-Y anoplasty in the treatment of chronic anal fissure.

Authors:  Alaa Magdy; Ayman El Nakeeb; El Yamani Fouda; Mohamed Youssef; Mohamed Farid
Journal:  J Gastrointest Surg       Date:  2012-08-07       Impact factor: 3.452

8.  The Role of Lateral Internal Sphincterotomy in Haemorrhoidectomy: A Study in a Tertiary Care Center.

Authors:  Shashikanth Vijayaraghavalu; Guru Prasad R; Sathish Rajkumar
Journal:  Cureus       Date:  2021-06-13

9.  Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a non-randomized controlled trial.

Authors:  Adnan Giral; Kemal Memisoglu; Yücel Gültekin; Neşe Imeryüz; Cem Kalayci; Nefise B Ulusoy; Nurdan Tözün
Journal:  BMC Gastroenterol       Date:  2004-03-22       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.